000 02191 a2200577 4500
005 20250513183134.0
264 0 _c19990625
008 199906s 0 0 eng d
022 _a0006-291X
024 7 _a10.1006/bbrc.1999.0715
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoide, M
245 0 0 _aBone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cMay 1999
300 _a97-102 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActivins
650 0 4 _aAnimals
650 0 4 _aBone Development
_xdrug effects
650 0 4 _aBone Marrow Cells
650 0 4 _aBone Morphogenetic Protein 2
650 0 4 _aBone Morphogenetic Proteins
_xpharmacology
650 0 4 _aCarrier Proteins
_xmetabolism
650 0 4 _aCyclooxygenase 2
650 0 4 _aCyclooxygenase 2 Inhibitors
650 0 4 _aCyclooxygenase Inhibitors
_xpharmacology
650 0 4 _aGene Expression Regulation, Developmental
650 0 4 _aIndomethacin
_xpharmacology
650 0 4 _aInhibins
_xpharmacology
650 0 4 _aInterleukin-1
_xpharmacology
650 0 4 _aIsoenzymes
_xmetabolism
650 0 4 _aMembrane Glycoproteins
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aNitrobenzenes
_xpharmacology
650 0 4 _aOsteoclasts
_xphysiology
650 0 4 _aProstaglandin-Endoperoxide Synthases
_xmetabolism
650 0 4 _aRANK Ligand
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aReceptor Activator of Nuclear Factor-kappa B
650 0 4 _aSulfonamides
_xpharmacology
650 0 4 _aTransforming Growth Factor beta
_xpharmacology
650 0 4 _aUp-Regulation
_xgenetics
700 1 _aMurase, Y
700 1 _aYamato, K
700 1 _aNoguchi, T
700 1 _aOkahashi, N
700 1 _aNishihara, T
773 0 _tBiochemical and biophysical research communications
_gvol. 259
_gno. 1
_gp. 97-102
856 4 0 _uhttps://doi.org/10.1006/bbrc.1999.0715
_zAvailable from publisher's website
999 _c10293742
_d10293742